A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Clinical trial NCT02608359 · WITHDRAWN
Trial details
- NCT number
- NCT02608359
- Sponsor
- Johnson & Johnson Private Limited
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-05-31
- Primary completion
- 2022-05-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.